Source link : https://www.newshealth.biz/health-news/semaglutide-2-4-mg-could-cut-medical-costs-for-some/
SAN ANTONIO — Semaglutide 2.4 mg (Wegovy) was associated with a 22% reduction in annual medical costs in people with overweight/obesity and heart failure, new research from Novo Nordisk found. The significant year-to-year reduction of more than $6500 in total medical costs suggests that the drug “can be an attractive treatment option for this population,” […]
Author : News Health
Publish date : 2024-11-14 08:03:58
Copyright for syndicated content belongs to the linked Source.